Hikma Launches New 503B Sterile Compounding Business
LONDON, UK: Hikma Pharmaceuticals, the multinational pharmaceutical company, announced the launch of Hikma 503B – a new outsourced sterile compounding business focused on providing high quality, ready-to-administer injectable medications that are customized to the specific needs of patients in the…